All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
M. Roelens(BIOASTER), Constantin Sluka, Hans H. Hirsch(Department of Biomedicine Basel), Markus H. Heim(University of Basel), Francesco Negro(University Hospital of Geneva), Vincent Aubert, Christoph Junker(Federal Statistical Office), Beat Müllhaupt(University Hospital of Zurich), Nasser Semmo, Thomas Fabbro, Laurent Kaiser(University Hospital of Geneva), Darius Moradpour(University Hospital of Lausanne), Hans H. Siegrist(Epatocentro Ticino), Pascal Benkert(University of Basel), David Semela(Kantonsspital St. Gallen), Elsbeth Probst‐Müller, Marielle Rutquist, Gladys Martinetti-Lucchini(Hospital Neuchâtel), Olivier Clerc(Hospital Neuchâtel), Andreas Cerny(Epatocentro Ticino), G Dollenmaier(University of St.Gallen), Barbara Bertisch(Kantonsspital St. Gallen), Franziska Suter(University of Lausanne), Olivia Keiser(University of Geneva)
Cited by 7
Related Papers
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857